Product Detail
N4-Hydroxycytidine-13C,15N2
Cytidine Stable Isotopes
Stock Status: In Stock
Login to view price
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotopes
API Family
Cytidine
Storage
Store at refrigerator (2-8°C) for long term storage
Hazard Information
Refer MSDS for complete information.
N4-Hydroxycytidine-13C,15N2 Product Information
N4-Hydroxycytidine-13C,15N2 is listed under Stable Isotopes. It is associated with Cytidine and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-O-40149.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
N4-Hydroxycytidine-13C,15N2
CAS No.
3258-02-4 (Unlabelled)
CAT No.
CS-O-40149
Molecular Formula
C813CH13N15N2O6
Molecular Weight
262.20
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
SMILES
O/N=C1C=C[15N]([C@H]2[C@H](O)[C@H](O)[C@@H](CO)O2)[13C]([15NH]/1)=O
IUPAC Name
(Z)-1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(hydroxyimino)-3,4-dihydropyrimidin-2(1H)-one-2-13C-1,3-15N2
Purity by HPLC
100.00%
Hazard Compound
Refer MSDS for complete information.
Description
Overview
EIDD 1931-13C,15N2 is a labelled EIDD 1931(E985800), which is an orally bioavailable broad-spectrum antiviral that inhibits SARS-CoV-2 and other multiple endemic, epidemic and bat coronavirus and has the potential for seasonal and pandemic influenza treatment. A broad-spectrum ribonucleoside analog inhibitor of influenza and respiratory syncytial viruses.
Synonyms
(Z)-1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(hydroxyimino)-3,4-dihydropyrimidin-2(1H)-one-2-13C-1,3-15N2
Application Notes
EIDD 1931-13C,15N2 is a labelled EIDD 1931(E985800), which is an orally bioavailable broad-spectrum antiviral that inhibits SARS-CoV-2 and other multiple endemic, epidemic and bat coronavirus and has the potential for seasonal and pandemic influenza treatment. A broad-spectrum ribonucleoside analog inhibitor of influenza and respiratory syncytial viruses.
References
Sheahan, T. P., et al.: Sci. Transl. Med., 12, eabb5883 (2020); Agostini, M. L., et al.: J. Virol., 93, 01348 (2019); Yoon, J., et al.: Antimicrob. Agents and Chemother., 62, 00766 (2018); Barnard, D. L., et al.: Antivir. Chem. Chemother., 17, 275 (2006)
